The debut of Fabtech Technologies shares on the stock exchanges was marked by a muted start. On the BSE, the stock listed at ₹191 per share, exactly matching its IPO price. On the NSE, it opened slightly higher at ₹192, reflecting a minor 0.52% premium.
Despite the quiet listing, the IPO drew attention from investors following a strong subscription during the bidding process, highlighting consistent interest in the engineering solutions sector for pharmaceuticals and healthcare.
Market Performance
Fabtech Technologies’ IPO performance today showed stability, with the listing price closely aligned with the issue price.
Key details:
- BSE Listing Price: ₹191 (flat)
- NSE Listing Price: ₹192 (0.52% premium)
- IPO Size: ₹230 crore
- Number of Shares: 1.2 crore equity shares
- Price Band: ₹181–191 per share
The listing indicates a measured market response, reflecting the IPO’s position in a niche sector with specialized clientele and established international operations.
Fabtech Technologies IPO Overview
The company raised funds entirely through a fresh issue, with proceeds earmarked for strategic purposes:
- Working capital requirements to support day-to-day operations
- Inorganic growth initiatives through potential acquisitions
- General corporate purposes
The IPO provided investors an opportunity to participate in a company offering turnkey engineering solutions for the pharmaceutical, biotechnology, and healthcare industries.
Company Details
Fabtech Technologies provides end-to-end solutions for clients, covering:
- Designing and engineering of pharmaceutical equipment
- Procurement, installation, and testing of select machinery
- Execution of complex turnkey projects for a wide range of customers
The company has a growing international footprint. As of June 2024, it completed 35 projects across several countries, including:
- Saudi Arabia
- Egypt
- Algeria
- Bangladesh
- Ethiopia
- Sri Lanka
- UAE
This global presence underlines the company’s ability to deliver high-quality engineering solutions across different regulatory environments and industries.
Summary
In summary, Fabtech Technologies’ market debut was steady, with shares listing largely at the IPO price. The ₹230 crore IPO raised through 1.2 crore fresh equity shares provides the company with capital to strengthen operations, pursue acquisitions, and maintain corporate flexibility.
The firm’s established international project portfolio, combined with its focus on the pharmaceutical and healthcare sector, positions it as a specialized player with growth potential in niche engineering solutions.
Easy & quick
Leave A Comment?